Adenocarcinoma Of Esophagus Recruiting Phase 2 / 3 Trials for Docetaxel (DB01248)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01404156Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ AdenocarcinomaTreatment